These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1313173)

  • 81. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
    Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
    Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex.
    de Miranda P; Good SS; Yarchoan R; Thomas RV; Blum MR; Myers CE; Broder S
    Clin Pharmacol Ther; 1989 Nov; 46(5):494-500. PubMed ID: 2582706
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase.
    Pontikis R; Dollé V; Guillaumel J; Dechaux E; Note R; Nguyen CH; Legraverend M; Bisagni E; Aubertin AM; Grierson DS; Monneret C
    J Med Chem; 2000 May; 43(10):1927-39. PubMed ID: 10821705
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice.
    Hostetler KY; Korba BE; Sridhar CN; Gardner MF
    Antiviral Res; 1994 May; 24(1):59-67. PubMed ID: 7944313
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of antiretroviral dideoxynucleosides on polymorphonuclear leukocyte function.
    Roilides E; Venzon D; Pizzo PA; Rubin M
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1672-7. PubMed ID: 2178334
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.
    Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetic interaction between rifampin and zidovudine.
    Burger DM; Meenhorst PL; Koks CH; Beijnen JH
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1426-31. PubMed ID: 8363370
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles.
    Bender A; Schfer V; Steffan AM; Royer C; Kreuter J; Rübsamen-Waigmann H; von Briesen H
    Res Virol; 1994; 145(3-4):215-20. PubMed ID: 7800948
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The effect of acetaminophen on zidovudine metabolism in HIV-infected patients.
    Steffe EM; King JH; Inciardi JF; Flynn NF; Goldstein E; Tonjes TS; Benet LZ
    J Acquir Immune Defic Syndr (1988); 1990; 3(7):691-4. PubMed ID: 2352121
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients.
    Nokta M; Loh JP; Douidar SM; Ahmed AE; Pollard RB
    J Interferon Res; 1991 Jun; 11(3):159-64. PubMed ID: 1919075
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients.
    Liu LF; Wang L; Fu Q; Zhu Z; Xie J; Han Y; Liu ZY; Ye M; Li TS
    Chin Med J (Engl); 2012 Jun; 125(11):1931-5. PubMed ID: 22884056
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Canadian multicenter azidothymidine trial: AZT pharmacokinetics.
    Child S; Montaner J; Tsoukas C; Fanning M; Le T; Wall RA; Ruedy J
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):865-70. PubMed ID: 1895207
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Zidovudine kinetics in the pregnant baboon.
    Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Feb; 11(2):117-27. PubMed ID: 8556393
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of gender, pregnancy, and anesthesia on the pharmacokinetics of zidovudine in rats.
    Huang CS; Boudinot FD; Feldman S
    Pharm Res; 1995 Nov; 12(11):1647-51. PubMed ID: 8592664
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Comparative pharmacokinetics and interspecies scaling of 3'-azido-3'-deoxythymidine (AZT) in several mammalian species.
    Patel BA; Boudinot FD; Schinazi RF; Gallo JM; Chu CK
    J Pharmacobiodyn; 1990 Mar; 13(3):206-11. PubMed ID: 2115580
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice.
    Gallo JM; Etse JT; Doshi KJ; Boudinot FD; Chu CK
    Pharm Res; 1991 Feb; 8(2):247-53. PubMed ID: 2023876
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.
    Song H; Griesgraber GW; Wagner CR; Zimmerman CL
    Antimicrob Agents Chemother; 2002 May; 46(5):1357-63. PubMed ID: 11959569
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta.
    Bawdon RE; Sobhi S; Dax J
    Am J Obstet Gynecol; 1992 Dec; 167(6):1570-4. PubMed ID: 1335207
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer.
    Shojaei AH; Khan M; Lim G; Khosravan R
    Int J Pharm; 1999 Dec; 192(2):139-46. PubMed ID: 10567745
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of six virustatic nucleoside analogues on the development of fetal rat thymus in organ culture.
    Foerster M; Kastner U; Neubert R
    Arch Toxicol; 1992; 66(10):688-99. PubMed ID: 1337823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.